Table 5: One and two-year relative survival (with 95% confidence intervals) according to sex by age and histological type for lung cancer patients diagnosed in 2011–2012.
|
|
Men |
Women |
||
|
|
One-year RS (95% CI) |
Two-year RS (95% CI) |
One-year RS (95% CI) |
Two-year RS (95% CI) |
|
Age |
|
|||
|
15-44 |
30.0 (12.8 – 70.4) |
10.0 (2.3 – 42.8) |
50.0 (24.6 – 100) |
50.0 (24.6 – 100) |
|
45-54 |
31.2 (20.4 – 47.8) |
15.2 (6.8 – 34.2) |
57.7 (43.3 – 76.9) |
33.7 (20.7 – 54.9) |
|
55-64 |
44.2 (36.1 – 54.1) |
23.0 (15.6 – 33.8) |
40.9 (26.3- 63.5) |
28.7 (16.0 – 51.5) |
|
65-74 |
33.9 (27.6 – 41.5) |
17.3 (12.4 – 24.4) |
71.8 (52.3 – 98.7) |
40.8 (21.9 – 75.8) |
|
≥ 75 |
21.1 (16.0 – 27.7) |
10.7 (6.9 – 16.4) |
30.0 (17.7 – 51.0) |
14.5 (5.9 – 35.7) |
|
Histologic type |
||||
|
ADC |
39.4 (32.3 – 48.0) |
17.0 (11.6 – 25.0) |
54.3 (43.3 – 68.0) |
37.5 (26.8 – 52.4) |
|
SCC |
42.5 (35.4 – 50.9) |
24.7 (18.2 – 33.7) |
50.2 (26.7 – 94.4) |
18.9 (5.3 – 66.8) |
|
LCC |
34.4 (16.7 – 71.0) |
0 (0 – 0) |
100 (100 – 100) |
0.3 (0 – 2.1) |
|
Others |
12.9 (8.4 – 19.8) |
7.6 (4.1 – 14.1) |
29.1 (16.0 – 52.9) |
25.5 (12.8 – 50.9) |
|
SmCC |
25.4 (17.7 – 36.2) |
13.9 (7.9 – 24.2) |
43.2 (24.4 – 76.3) |
7.2 (1.6 – 32.1) |
CI confidence intervals, ADC adenocarcinoma, SCC squamous cell carcinoma, LCC large cell carcinoma, SmCC small cell carcinoma